Effect of liraglutide on subclinical atherosclerosis and cardiometabolic risk factors in adults with type 1 diabetes: A prospective pilot study
In adults with T1D, liraglutide improved several cardiometabolic risk factors and insulin sensitivity, although no significant short-term effects on CIMT were observed. Larger long-term trials are needed to clarify its potential role in cardiovascular prevention in this population.
Authors
- Yesica Luna‐Garza
- Kelly Danara Garza‐Davila
- Ana Livia Dominguez‐Rodriguez
- Rosa Alicia Huitron‐Ramirez
- Ricardo Rocha‐Rojas
- Graciela Gómez‐Martínez
- David Sánchez‐García
- Zinia Fernanda Martínez‐Mendoza
- Marcelo Diaz‐Sallas
- Eloísa Saavedra‐Castillo
- Janeth Patricia Martinez‐Rentería
- Alejandra Claudia Ortega‐Valdez
- Dania Lizet Quintanilla‐Flores
- Karina Rosa Reyes‐Valdez
Institutions
- Mexican Social Security Institute (MX)
- Centro Médico Nacional La Raza (MX)
Publication Details
- Journal
- Diabetic Medicine
- Published
- 2026-02-15
- DOI
- https://doi.org/10.1111/dme.70222
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00